ProShare Advisors’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $64.3K | Sell |
|
|||||
|
2025
Q1 | $68.7K | Sell |
|
|||||
|
2024
Q4 | $90.1K | Buy |
|
|||||
|
2024
Q3 | $66.7K | Buy |
|
|||||
|
2024
Q2 | $63K | Sell |
|
|||||
|
2024
Q1 | $58.3K | Buy |
|
|||||
|
2023
Q4 | $55K | Buy |
|
|||||
|
2023
Q3 | $47.9K | Sell |
|
|||||
|
2023
Q2 | $82.8K | Buy |
|
|||||
|
2023
Q1 | $81.6K | Sell |
|
|||||
|
2022
Q4 | $99.3K | Buy |
|
|||||
|
2022
Q3 | $122K | Buy |
|
|||||
|
2022
Q2 | $134K | Sell |
|
|||||
|
2022
Q1 | $203K | Sell |
|
|||||
|
2021
Q4 | $337K | Buy |
|
|||||
|
2021
Q3 | $349K | Sell |
|
|||||
|
2021
Q2 | $553K | Buy |
|
|||||
|
2021
Q1 | $354K | Buy |
|
|||||
|
2020
Q4 | $281K | Buy |
|
|||||
|
2020
Q3 | $158K | Sell |
|
|||||
|
2020
Q2 | $194K | Buy |
|
|||||
|
2020
Q1 | $117K | Sell |
|
|||||
|
2019
Q4 | $329K | Sell |
|
|||||
|
2019
Q3 | $288K | Sell |
|
|||||
|
2019
Q2 | $316K | Sell |
|
|||||
|
2019
Q1 | $460K | Buy |
|
|||||
|
2018
Q4 | $644K | Sell |
|
|||||
|
2018
Q3 | $634K | Sell |
|
|||||
|
2018
Q2 | $546K | Buy |
|
|||||
|
2018
Q1 | $449K | Sell |
|
|||||
|
2017
Q4 | $467K | Buy |
|
|||||
|
2017
Q3 | $506K | Buy |
|
|||||
|
2017
Q2 | $436K | Sell |
|
|||||
|
2017
Q1 | $390K | Sell |
|
|||||
|
2016
Q4 | $557K | Buy |
|
|||||
|
2016
Q3 | $514K | Sell |
|
|||||
|
2016
Q2 | $410K | Sell |
|
|||||
|
2016
Q1 | $309K | Sell |
|
|||||
|
2015
Q4 | $377K | Buy |
|
|||||
|
2015
Q3 | $409K | Sell |
|
|||||
|
2015
Q2 | $491K | Sell |
|
|||||
|
2015
Q1 | $382K | Buy |
|
|||||
|
2014
Q4 | $491K | Buy |
|
|||||
|
2014
Q3 | $321K | Sell |
|
|||||
|
2014
Q2 | $600K | Sell |
|
|||||
|
2014
Q1 | $962K | Buy |
|
|||||
|
2013
Q4 | $211K | Sell |
|
|||||
|
2013
Q3 | $358K | Buy |
|
|||||
|
2013
Q2 | $192K | Buy |
|